Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$11.06 - $12.87 $232,337 - $270,360
-21,007 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$9.33 - $12.48 $625,977 - $837,320
-67,093 Reduced 76.16%
21,007 $233,000
Q3 2020

Nov 06, 2020

BUY
$10.33 - $14.49 $412,435 - $578,527
39,926 Added 82.88%
88,100 $920,000
Q2 2020

Aug 17, 2020

BUY
$11.49 - $15.26 $264,258 - $350,964
22,999 Added 91.36%
48,174 $673,000
Q2 2020

Aug 11, 2020

SELL
$11.49 - $15.26 $153,242 - $203,522
-13,337 Reduced 34.63%
25,175 $354,000
Q1 2020

May 14, 2020

SELL
$8.11 - $15.23 $34,702 - $65,169
-4,279 Reduced 10.0%
38,512 $453,000
Q4 2019

Feb 06, 2020

BUY
$10.28 - $14.38 $296,742 - $415,093
28,866 Added 207.3%
42,791 $540,000
Q3 2019

Nov 12, 2019

SELL
$10.05 - $14.55 $7,547 - $10,927
-751 Reduced 5.12%
13,925 $147,000
Q2 2019

Aug 14, 2019

SELL
$13.1 - $14.95 $40,072 - $45,732
-3,059 Reduced 17.25%
14,676 $214,000
Q1 2019

May 15, 2019

BUY
$13.69 - $20.06 $213,550 - $312,915
15,599 Added 730.29%
17,735 $249,000
Q4 2018

Feb 13, 2019

SELL
$13.96 - $18.26 $656 - $858
-47 Reduced 2.15%
2,136 $33,000
Q3 2018

Nov 08, 2018

SELL
$13.63 - $15.7 $160,138 - $184,459
-11,749 Reduced 84.33%
2,183 $34,000
Q2 2018

Aug 03, 2018

BUY
$13.44 - $17.59 $9,542 - $12,488
710 Added 5.37%
13,932 $193,000
Q1 2018

May 11, 2018

BUY
$13.8 - $16.99 $14,503 - $17,856
1,051 Added 8.64%
13,222 $220,000
Q4 2017

Feb 08, 2018

BUY
$11.73 - $14.75 $27,413 - $34,470
2,337 Added 23.76%
12,171 $172,000
Q3 2017

Nov 06, 2017

BUY
$12.06 - $14.12 $118,598 - $138,856
9,834
9,834 $138,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.